BridgeMD
New treatment option for Dyslipidemias
Official title Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity
ClinicalTrials.gov ID: NCT05700916
What this study is testing
What is Milk Polar Lipid-Rich Dairy Powder?
Milk Polar Lipid-Rich Dairy Powder is an investigational medicine, given as an once-daily, being studied as a potential treatment for dyslipidemias.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.
- Phase 1: an early, usually small safety study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70. Healthy volunteers may be eligible.
You may be able to join if
- LDL-C ≥ 130 mg/dL
- Waist circumference ≥ 88 cm for women, ≥ 102 cm for men
- Aged 18 to 70 years
You likely can't join if
- Renal disease
- Liver disease
- Diabetes
- Heart disease
- Stroke
- Cancer
See the full eligibility criteria
- LDL-C ≥ 130 mg/dL
- Waist circumference ≥ 88 cm for women, ≥ 102 cm for men
- Aged 18 to 70 years
- Renal disease
- Liver disease
- Diabetes
- Heart disease
- Stroke
- Cancer
- Eating disorders
- Thyroid disease
- Gut-associated pathologies
- Autoimmune diseases
- Chronic inflammatory diseases
- Scleroderma
- Gallbladder disease
- Blood clotting disorders
- Intravenous drug use
- Fasting plasma/serum triglycerides \>500 mg/dL
- Fasting plasma/serum glucose \>126 mg/d
- Weight changes \>10% over last 4 weeks
- Oral antibiotics use up to 1 month prior to and during study
- Allergy or intolerance to milk products
- Taking lipid-lowering medications (e.g., statins, fibrates)
- Taking anti-inflammatory medications (e.g., corticosteroids)
- Taking medications which primarily affect blood clotting (e.g., warfarin).
The study team makes the final eligibility decision.
Where it's taking place
- Storrs, Connecticut, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Storrs, Connecticut, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.